INVO BIOSCIENCE INC - COM (INVO)

CUSIP: 44984F302

Q1 2023 13F Holders as of 31 Mar 2023

Share change
+1,099,162
SEC-reported price per share
$0.64
Indexed holders
21
Value change
+$717,112
Number of buys
7
Number of sells
7

Security key

44984F302

Report period

Q1 2023

Indexed institutions

21

Top holders

10

Ownership snapshot

Top reported holders of INVO - INVO BIOSCIENCE INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
AWM Investment Company, Inc.
Disclosed value leader
AWM Investment Company, Inc.
Comparable rows
0/15
Latest evidence
31 Dec 2022
3/4/5 13F Highest disclosed value: $1,101,121 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

AWM Investment Company, Inc. has the largest disclosed position value at $1.1M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens AWM Investment Company, Inc.'s linked filing trail.
Disclosed position value Top 5
AWM Investment Company, Inc. $1.1M
VANGUARD GROUP INC $155.7K
GEODE CAPITAL MANAGEMENT, LLC $37K
Jeffrey Segal $26.8K
IEQ CAPITAL, LLC $21.2K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
AWM Investment Company, Inc.
3/4/5 13F
10%+ Owner · Company
—
denominator unverified
$1,101,121
1,159,075 shares
— 01 Oct 2021
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$155,700
367,390 shares
— 31 Dec 2022
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$37,000
87,194 shares
— 31 Dec 2022
Jeffrey Segal
3/4/5
Director
—
denominator unverified
$26,809
28,220 shares
— 01 Jun 2022
IEQ CAPITAL, LLC
13F
Company
13F
—
denominator unverified
$21,190
50,000 shares
— 31 Dec 2022
CITADEL ADVISORS LLC
13F
Company
13F
—
denominator unverified
$21,169
48,664 shares
— 31 Dec 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
21
Shares
2,412,873
Indexed holders
21
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q1 2023 vs Q4 2022 Across Filers

Q4 2022 indexed holders
19
Q1 2023 indexed holders
21
Indexed holder difference
2
Investor Q4 2022 Shares Q1 2023 Shares Share Diff Share Chg % Q4 2022 value Q1 2023 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .